ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "RNA"

  • Abstract Number: 1931 • 2018 ACR/ARHP Annual Meeting

    Abundance of Plasma Microbial Small RNAs Are Predictive of Improvement in Disease Activity after DMARD Initiation for Rheumatoid Arthritis

    Michelle J. Ormseth1, Quanhu Sheng1, Shilin Zhao1, Joseph F. Solus1, Qiong Wu1, Ryan Allen1, Yan Guo1, Fei Ye1, Marisol Ramirez1, Kasey Vickers1, S. Louis Bridges Jr.2, Jeffrey R. Curtis3 and C Michael Stein1, 1Vanderbilt University Medical Center, Nashville, TN, 2Clinical Immunology & Rheum, Univ of Alabama, Birmingham, AL, 3University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Small RNAs (sRNAs) are important regulators of biological processes and are potential biomarkers of disease and drug response. We previously found that microbial sRNAs…
  • Abstract Number: 1967 • 2018 ACR/ARHP Annual Meeting

    Detection of Association of Long Noncoding RNA ATP6V0E2-AS1 Single Nucleotide Polymorphism with Susceptibility to Myeloperoxidase-ANCA Associated Vasculitis Based on Transcriptome Analysis

    Yuka Iwahashi1,2, Aya Kawasaki1,2, Takayo Tsuchiura3, Ken-ei Sada4, Fumio Hirano5,6, Daisuke Tsukui7, Shigeto Kobayashi8, Hidehiro Yamada9, Hiroshi Furukawa1,2,10, Kenji Nagasaka11, Takahiko Sugihara12, Nao Nishida3, Kunihiro Yamagata13, Takayuki Sumida14, Shigeto Tohma10,15, Shoichi Ozaki9, Hiroshi Hashimoto16, Hirofumi Makino17, Yoshihiro Arimura18, Hajime Kono19, Masayoshi Harigai20 and Naoyuki Tsuchiya1,2, 1University of Tsukuba, Graduate School of Comprehensive Human Sciences, Masters' Program in Medical Sciences, Tsukuba, Japan, 2University of Tsukuba, Faculty of Medicine, Molecular and Genetic Epidemiology Laboratory, Tsukuba, Japan, 3Genome Medical Science Project, National Center for Global Health and Medicine, Research Center for Hepatitis and Immunology, Ichikawa, Japan, 4Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 5Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Department of Rheumatology, Tokyo, Japan, 6Tokyo Medical and Dental UniversityGraduate School of Medical and Dental Sciences, Department of Lifetime Clinical Immunology, Tokyo, Japan, 7Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 8Department of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan, 9St. Marianna University, School of Medicine, Department of Internal Medicine, Kawasaki, Japan, 10National Hospital Organization Sagamihara l Hospital, Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan, 11Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan, 12Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 13University of Tsukuba, Faculty of Medicine, Department of Nephrology, Tsukuba, Japan, 14Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 15National Hospital Organization Tokyo National Hospital, Kiyose, Japan, 16Juntendo University School of Medicine, Tokyo, Japan, 17Okayama University Hospital, Okayama, Japan, 18Kyorin University School of Medicine, First Department of Internal Medicine, Tokyo, Japan, 19Teikyo University School of Medicine, Department of Internal Medicine, Tokyo, Japan, 20Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan

    Background/Purpose: Because of the low prevalence, only three genome-wide association studies, all from the Caucasian populations, have been reported on ANCA-associated vasculitis (AAV) thus far;…
  • Abstract Number: 2018 • 2018 ACR/ARHP Annual Meeting

    Microenvironment Driven Re-Shaping of Pathogenic T Effector and Regulatory Subset in Active Juvenile Idiopathic Arthritic Patients

    Jing Yao Leong1, Pavanish Kumar1, Phyllis Chen2, Joo Guan Yeo2,3, Camillus Chua2, Sharifah Nur Hazirah2, Suzan Saidin1, Thaschawee Arkachaisri2,3, Alessandro Consolaro4, Marco Gattorno5, Alberto Martini6 and Salvatore Albani2, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 3KK Women's and Children's Hospital, Singapore, Singapore, 4Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genova, Italy, 5Second Paediatric Division, University of Genoa and G Gaslini Institute, Genova, Italy, Genoa, Italy, 6Pediatric Rheumatology International Trial Organization (PRINTO) Coordinating Centre, Genoa, Italy

    Background/Purpose: We have previously identified two CD4 pathogenic circulatory subsets in both T effector (CPLs) and T regulatory (iaTreg) compartments that are both HLA-DR+, antigen…
  • Abstract Number: 2055 • 2018 ACR/ARHP Annual Meeting

    Laser Capture Microdissection to Interrogate B Cells in RA Synovial Tissue

    Javier Rangel-Moreno1, Nida Meednu2, Andrew McDavid3, Linda Callahan4, V. Kaye Thomas4, Jennifer Albrecht2, Edward F. DiCarlo5, Dana Orange6, Susan M. Goodman6, Laura T. Donlin7 and Jennifer Anolik2, 1Medicine- Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 3Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, 4University of Rochester Medical Center, Rochester, NY, 5Laboratory Medicine, Hospital for Special Surgery, New York, NY, 6Hospital for Special Surgery, New York, NY, 7Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Rheumatoid arthritis is an autoimmune disease characterized by immune cell infiltration in synovial tissue and progressive bone damage. B cells are abundant in the…
  • Abstract Number: 2324 • 2017 ACR/ARHP Annual Meeting

    Single Cell RNA-Sequencing of Bone Marrow Macrophages Identifies a Distinct Subpopulation in Systemic JIA with Features of Interferon Response, Endocytic Vesicles and Phagocytosis

    Grant Schulert1, Nathan Salomonis2, Sherry Thornton3 and Alexei A. Grom4, 1Pediatric Rheumatology, Division of Pediatric Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Division of Pediatric Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States Minor Outlying Islands

    Background/Purpose: Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile idiopathic arthritis (SJIA), characterized by activation and expansion of cytolytic lymphocytes and macrophages…
  • Abstract Number: 2432 • 2017 ACR/ARHP Annual Meeting

    Longitudinal Changes in Gene Expression Associated with Disease Activity during Pregnancy and Post-Partum Among Women with Rheumatoid Arthritis

    Dana E. Goin1,2, Mette Smed3, Nicholas Jewell2, Lior Pachter2,4, J. Lee Nelson5,6, Hanne Kjaergaard3, Jørn Olsen7, Merete Lund Hetland8,9, Bent Ottesen3, Vibeke Zoffmann3 and Damini Jawaheer1,7,10, 1UCSF Benioff Children's Hospital Oakland/CHORI, Oakland, CA, 2University of California, Berkeley, Berkeley, CA, 3Juliane Marie Center, Copenhagen, Denmark, 4California Institute of Technology, Pasadena, CA, 5Fred Hutchinson Cancer Research Center, Seattle, WA, 6University of Washington, Seattle, WA, 7Aarhus University, Aarhus, Denmark, 8The DANBIO registry and the Danish Departments of Rheumatology, Glostrup, Denmark, 9University of Copenhagen, Copenhagen, Denmark, 10University of California, San Francisco, San Francisco, CA

    Background/Purpose: Many women with rheumatoid arthritis (RA) experience an improvement in disease activity during pregnancy, and a predictable flare in the months after they give…
  • Abstract Number: 2575 • 2017 ACR/ARHP Annual Meeting

    The Role of Interferon in Autoimmune-Susceptible Ro60 Knockout Mice

    Masaoki Kawasumi1, Daiki Rokunohe1, Edward Chiou2, Xizhang Sun2, Lena Tanaka2, Sandra L. Wolin3 and Keith B. Elkon4, 1Medicine/Dermatology, University of Washington, Seattle, WA, 2Medicine/Rheumatology, University of Washington, Seattle, WA, 3RNA Biology Laboratory, National Cancer Institute, Frederick, MD, 4Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA

    Background/Purpose: The Ro60 protein is a prominent autoantigen in systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). Anti-Ro antibodies are strongly associated with UV-mediated skin…
  • Abstract Number: 2757 • 2017 ACR/ARHP Annual Meeting

    Kidney and Skin Single-Cell RNA Sequencing in Lupus Nephritis Provides Mechanistic Insights and Novel Potential Biomarkers

    Evan Der1, Hemant Suryawanshi2, Saritha Ranabothu3, Beatrice Goilav4, H. Michael Belmont5, Peter M. Izmirly6, Nicole Bornkamp5, Nicole Jordan7, Tao Wang1, Ming Wu6, Judith A. James8, Joel M. Guthridge9, Soumya Raychaudhuri10, Thomas Tuschl11, Jill P. Buyon12 and Chaim Putterman13, 1Albert Einstein College of Medicine, Bronx, NY, 2The Rockefeller University, New York, NY, 3Nephrology, Children's Hospital at Montefiore, Bronx, NY, 4Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, 5Medicine, New York University School of Medicine, New York, NY, 6New York University School of Medicine, New York, NY, 7Montefiore Medical Center, New York, NY, 8Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 9Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 10Divisions of Genetics and Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 11Rockefeller University, New York, NY, 12Rheumatology, New York University School of Medicine, New York, NY, 13Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY

    Background/Purpose: Classification and treatment decisions in lupus nephritis (LN) are largely based on renal histology. Single-cell RNAseq (scRNAseq) analysis may accurately differentiate types of renal…
  • Abstract Number: 181 • 2017 ACR/ARHP Annual Meeting

    Identification of Disease-Susceptible Lncrna Contributed to Abnormal Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus

    Nan Shen1,2, Yuanjia Tang3, Zhixin Xue3 and Chaojie Cui4, 1Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China, 2The Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States of America, Cincinnati, OH, 3Shanghai Institute of Rheumatology,Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 4Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Background/Purpose: Dysregulation or dysfunction of some key moleculars in signaling pathway is involved in disease pathogenesis. Long non-coding RNA (lncRNA), as a regulator of gene…
  • Abstract Number: 302 • 2017 ACR/ARHP Annual Meeting

    From Monocytes to Macrophages:  the Pathogeneses of Spontaneous Inflammatory Arthritis in CD11c-Flip-KO (HUPO) Mice

    Qi Quan Huang1, Renee E. Doyle2, Philip J. Homan1, Harris Perlman3, Deborah R. WInter3 and Richard M. Pope2, 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: We have generated a CD11c-Flip-KO mouse line (HUPO) that spontaneously develops erosive arthritis with incidence 70-80% at age ≥ 20 weeks. This study aimed…
  • Abstract Number: 387 • 2017 ACR/ARHP Annual Meeting

    F4/80hi Synovial Macrophages in the Pathogeneses of Spontaneous Inflammatory Arthritis in CD11c-Flip-KO (HUPO) Mice

    Qi Quan Huang1,2, Renee E. Doyle2, Philip J. Homan1, Harris Perlman3, Deborah R. WInter4 and Richard M. Pope2, 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Synovial tissue macrophages (STMs) are critical in the pathogenesis of rheumatoid arthritis (RA). During homeostasis, the majority of murine synovial tissue resident macrophages (TRMs)…
  • Abstract Number: 770 • 2017 ACR/ARHP Annual Meeting

    Integrating Analysis of Skin RNA in Situ Hybridization Using Rnascope and Whole Skin Gene Expression in Systemic Sclerosis Skin to Localize Key Pathogenic Drivers of Skin Fibrosis

    Corrado Campochiaro1, Emma C. Derrett-Smith1, Voon H. Ong2, Gail Pearse3, Katherine Nevin3, Shaun Flint3, Mary Morse3, Nicolas Wisniacki4 and Christopher Denton5, 1Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine, London, United Kingdom, 2Rheumatology, UCL Division of Medicine, London, United Kingdom, 3GlaxoSmithKline, Stevenage, United Kingdom, 4ImmunoImflammation, GlaxoSmithKline, Stevenage, United Kingdom, 5Department of Rheumatology, University College London, Royal Free Hospital, London, United Kingdom

    Background/Purpose: Skin gene expression profiling can distinguish SSc from normal skin and can detect different subsets of disease. Previous studies have reported a cross-sectional relationship…
  • Abstract Number: 1026 • 2017 ACR/ARHP Annual Meeting

    Gene Expression Analysis Reveals Common Pathways of Tissue Pathogenesis in Lupus Organ Involvement

    Amrie Grammer1, Sarah Heuer1, Robert Robl1, Adam Labonte1, Prathyusha Bachali1, Sushma Madamanchi1 and Peter E. Lipsky2, 1AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA, 2AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Lupus is a prototypic autoimmune disease characterized by B cell hyperactivity, autoantibody formation and resultant tissue damage. The mechanisms underlying tissue pathology in lupus…
  • Abstract Number: 1330 • 2017 ACR/ARHP Annual Meeting

    Rhesus Theta Defensin 1 (RTD-1) Suppresses Disease-Associated Genes and Induces Anti-Inflammatory Expression Signature in Synovial Tissues of Rat Model of Rheumatoid Arthritis

    Prasad Tongaonkar1, Vasu Punj2, Akshay Subramanian3, Dat Tran3, Katie Trinh4, Justin Schaal1, Percio S. Gulko5, Andre Oullette3 and Michael Selsted3, 1Pathology and Laboratory Medicine, Keck School of Medicine University of Southern California, Los Angeles, CA, 2Medicine, Keck School of Medicine University of Southern California, Los Angeles, CA, 3Keck School of Medicine University of Southern California, Los Angeles, CA, 4Pathology, Keck School of Medicine University of Southern California, Los Angeles, CA, 5Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Theta (θ) defensins are the only known macrocyclic peptides found in the Animal kingdom and are exclusively expressed in Old World monkeys. θ-defensins were…
  • Abstract Number: 1721 • 2017 ACR/ARHP Annual Meeting

    Long Noncoding RNA H19X Is a Key Regulator of Apoptosis and Proliferation of Fibroblasts in Systemic Sclerosis and Other TGFβ-Driven Fibrotic Diseases

    Elena Pachera1, Adam Wunderlin1, Shervin Assassi2, Gloria Salazar2, Mojca Frank Bertoncelj1, Rucsandra Dobrota1, Matthias Brock3, Carol A. Feghali-Bostwick4, Gerard Dijkstra5, Gerhard Rogler6, Tobias van Haaften Wouter6, Jörg Distler7, Gabriela Kania1 and Oliver Distler1, 1Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 3Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland, 4Division of Rheumatology and Immunology, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, United States, Charleston, SC, 5Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, Switzerland, 6Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, 7Internal Medicine 3, University of Erlangen, Erlangen, Germany

    Background/Purpose: Long noncoding RNAs (lncRNAs) are a class of transcripts regulating gene expression. We have recently identified a novel lncRNA, H19X, which was upregulated in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology